Related references
Note: Only part of the references are listed.Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy
Kailin Xing et al.
BMC IMMUNOLOGY (2015)
EASL Clinical Practice Guidelines: Autoimmune hepatitis
JOURNAL OF HEPATOLOGY (2015)
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
Eoin F. McKinney et al.
NATURE (2015)
Programmed death-1 pathway in cancer and autoimmunity
Ariel Pedoeem et al.
CLINICAL IMMUNOLOGY (2014)
Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells
J. J. Pen et al.
GENE THERAPY (2014)
Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis
Yasuhiro Miyake et al.
HEPATOLOGY RESEARCH (2014)
Circulating T follicular regulatory and helper cells have memory-like properties
Peter T. Sage et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis
Kazuyuki Matsumoto et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis
S. R. Greisen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Autoimmune hepatitis: A comprehensive review
Rodrigo Liberal et al.
JOURNAL OF AUTOIMMUNITY (2013)
Dysregulated Generation of Follicular Helper T Cells in the Spleen Triggers Fatal Autoimmune Hepatitis in Mice
Nobuhiro Aoki et al.
GASTROENTEROLOGY (2011)
Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma
Bao-Ju Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Diagnosis and Management of Autoimmune Hepatitis
Michael P. Manns et al.
HEPATOLOGY (2010)
T-cell exhaustion: characteristics, causes and conversion
John S. Yi et al.
IMMUNOLOGY (2010)
Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling
Masahiro Kido et al.
GASTROENTEROLOGY (2008)
Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease
Tsunekazu Oikawa et al.
PATHOLOGY INTERNATIONAL (2007)
PD-1 and PD-1 ligands: from discovery to clinical application
Taku Okazaki et al.
INTERNATIONAL IMMUNOLOGY (2007)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo
Han Xiao et al.
CLINICAL CANCER RESEARCH (2007)
Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatois arthritis
Bing Wan et al.
JOURNAL OF IMMUNOLOGY (2006)
Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
JJ Feld et al.
HEPATOLOGY (2005)
Alternative splice variants of the human PD-1 gene
C Nielsen et al.
CELLULAR IMMUNOLOGY (2005)
B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes
HD Dong et al.
IMMUNITY (2004)
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
MS Longhi et al.
JOURNAL OF HEPATOLOGY (2004)
Fulminant Hepatic Failure as the Initial Presentation of Acute Autoimmune Hepatitis
William R. Kessler et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
A Limmer et al.
NATURE MEDICINE (2000)
Share Paper
